Abstract
A 61-year-old male diagnosed as Borrmann type 3 advanced gastric cancer was operated, but could not be resected because of the invasion to the pancreas and the lymph nodes metastases. So, local administration of OK-432 20 KE, intra-abdominal administration of CDDP 50 mg, and long-term intermittent intravenous administration of MMC a total amount of 1480 mg, and oral administration of UFT were performed. As the result of this therapy, the tumor was reduced in size. Three years and seven months after the operation, he feels well. Because of this combined therapy, his renal function was made worse.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adenocarcinoma / drug therapy*
-
Adenocarcinoma / surgery
-
Administration, Oral
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Humans
-
Infusions, Parenteral
-
Injections, Intralesional
-
Male
-
Middle Aged
-
Mitomycin
-
Mitomycins / administration & dosage
-
Picibanil / administration & dosage
-
Remission Induction
-
Stomach Neoplasms / drug therapy*
-
Stomach Neoplasms / surgery
-
Tegafur / administration & dosage
-
Uracil / administration & dosage
Substances
-
Mitomycins
-
Tegafur
-
Picibanil
-
Mitomycin
-
Uracil
-
Cisplatin